Cellect Biotechnology Ltd (APOP):医療機器:M&Aディール及び事業提携情報

【英語タイトル】Cellect Biotechnology Ltd (APOP) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7890)・商品コード:DATA904C7890
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:39
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥55,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥83,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Cellect Biotechnology Ltd (Cellect Biotechnology) formerly Cellect Biomed Ltd is a clinical stage biotechnology company which develops stem cell selection technologies for the production of stem cells based products in the field of regenerative medicine. The company’s technology platform is developing ApoGraft solutions which provides functional selection of stem and progenitor cells through an apoptotic process with focus on hematopoietic cells field. It is developing ApoTainer selection kit, a off-the-shelf medical device product for use in bone marrow transplantation, immune disorders and organ transplantations. The company offers licensing opportunities to pharmaceutical companies, medical research centers, academies and hospitals with the tools to rapidly isolate stem cells and allow stem cell related treatments and procedures. Cellect Biotechnology is headquartered in Kfar Saba, Israel.

Cellect Biotechnology Ltd (APOP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cellect Biotechnology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Cellect Biotechnology Ltd, Medical Equipment, Deal Details 11
Partnerships 11
Cellect Biomed Enters into Co-Development Agreement with Entegris 11
Equity Offering 12
Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 12
Cellect Biotechnology Raises USD8.4 Million in IPO of ADS 13
Cellect Biomed Raises USD2 Million in Private Placement of Shares 15
Cellect Biotechnology Ltd – Key Competitors 16
Cellect Biotechnology Ltd – Key Employees 17
Cellect Biotechnology Ltd – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Financial Announcements 19
May 17, 2018: Cellect Biotechnology Provides Corporate Update and Reports First Quarter 2018 Financial Results 19
Mar 19, 2018: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results 20
Nov 22, 2017: Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2017 Financial Results 22
Aug 21, 2017: Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2017 Financial Results 23
May 29, 2017: Cellect Biotechnology Provides Corporate Update and Reports First Quarter 2017 Financial Results 24
Mar 23, 2017: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results 25
Corporate Communications 27
May 10, 2018: Former GE Healthcare Executive to Join Cellect as Chief Business Officer 27
May 23, 2017: David Braun, Head of Merck Device Business, Joins Cellect’s Advisory Board 28
Mar 02, 2017: Michael Berelowitz MD., Former Head, Clinical Development and Medical Affairs, Pfizer Specialty Care Business Unit Joins Cellect’s Board of Directors 29
Feb 23, 2017: World-Renowned Stem Cell Transplantation Expert joins Cellect’s Advisory Board 30
Jan 30, 2017: Dr. Yaron Pereg Appointed as New Chief Development Officer 31
Jan 03, 2017: Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer 32
Legal and Regulatory 33
Jun 09, 2017: Cellect is Moving to Trade Exclusively on the NASDAQ 33
Feb 14, 2017: Dual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange 34
Product News 35
Jun 12, 2017: Cellect Receives Notice of Allowance from the US Patent & Trademark Office 35
Apr 03, 2017: Cellect Receives Notice of Intention to Grant from European Patent Office for Patent Protecting Company’s Technology in Multiple Indications 36
Jan 12, 2017: Cellect Receives Patent Notice of Allowance from US Patent & Trademark Office Protecting Company’s Technology in Multiple Key Indications 37
Other Significant Developments 38
Apr 09, 2018: Cellect Announces a Major Milestone for Enabling Stem Cells Production 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Cellect Biotechnology Ltd, Medical Equipment, Key Facts, 2016 2
Cellect Biotechnology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Deals By Market, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Cellect Biomed Enters into Co-Development Agreement with Entegris 11
Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 12
Cellect Biotechnology Raises USD8.4 Million in IPO of ADS 13
Cellect Biomed Raises USD2 Million in Private Placement of Shares 15
Cellect Biotechnology Ltd, Key Competitors 16
Cellect Biotechnology Ltd, Key Employees 17

List of Figures
Cellect Biotechnology Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★調査レポート[Cellect Biotechnology Ltd (APOP):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C7890)販売に関する免責事項を必ずご確認ください。
★調査レポート[Cellect Biotechnology Ltd (APOP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆